RIL
VYGR icon

Rothschild Investment LLC’s Voyager Therapeutics VYGR Stock Holding History

Rothschild Investment LLC’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231 Buy
66
+31
+89% +$118 ﹤0.01% 3424
2026
Q1 		$135 Buy
+35
New +$138 ﹤0.01% 3366
2025
Q2 		– Sell
-30
Closed -$101 – 3201
2025
Q1 		$101 Sell
30
-65
-68% -$304 ﹤0.01% 2969
2024
Q4 		$539 Buy
+95
New +$612 ﹤0.01% 2507

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rothschild Investment LLC's VYGR Position: Q2 2026 in Review

Rothschild Investment LLC increased its Voyager Therapeutics (VYGR) stake by 89% in Q2 2026, buying an estimated $118 and bringing the position to 66 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #3424.

Rothschild Investment LLC first reported a position in VYGR in Q4 2024 and has held it in 4 quarters since. The position peaked at $539 in Q4 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Rothschild Investment LLC held 66 shares of Voyager Therapeutics worth $231 as of Q2 2026.
  • Rothschild Investment LLC bought 31 Voyager Therapeutics shares in Q2 2026, an estimated $118.
  • Voyager Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3424 holding.
  • Rothschild Investment LLC first reported a position in Voyager Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Rothschild Investment LLC's Voyager Therapeutics position peaked at $539 in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.